Introducing the NEW AscencioDx® Molecular Detector…

Where Speed, Efficiency, & Accuracy Align

The AscencioDx Molecular Detector, a rapid portable diagnostic tool, has become integral in medical settings, delivering positive results in as few as 20 minutes. This device is especially beneficial in environments such as physicians' offices, urgent care clinics, pharmacies, and other point-of-care facilities.

RADx® Funded-Company - Selected by the NIH for the highly competitive RADx development program

Proudly Manufactured in the USA to our strict quality standards.

Need

  • Promptly identify SARS-CoV-2, encompassing emerging variants, to ensure timely and effective patient triage

  • Optimize workflow processes with reduced manual intervention

Solution

  • Delivers positive test results in as few as 20 minutes, thus expediting decision-making and enhancing patient care

  • Incorporates three gene targets specific to SARS-CoV-2, complemented by optimized probes to enhance the reliability of virus detection

Impact

  • Provides healthcare professionals with laboratory-grade outcomes through point-of-care testing

  • Equips clinicians with comprehensive detection capabilities for SARS-CoV-2 variants using redundant genetic targets

  • Empowers clinicians to optimize resource utilization with a simple and user-friendly workflow